OKYO

OKYO Pharma Limited

HealthcareBiotechnologyGBUSDPeers →Country macro →

$1.59

LiveJun 08, 2026

AI Brief

Market cap

$61M

52w range

1.44 – 3.35

P / E

—

EPS

—

Volume

22.75K

Revenue · FY

—

Overview Profile Ratios Multiples Themes Earnings Prices Sentiment ESG

Explain this page

Arphra AIPlain-English read on OKYO Pharma Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$1.62

Change

-22.49%

Period high

$2.17

Period low

$1.51

Period start

$2.092026-02-02

Through 2026-06-05

Fair value

Football field →

Weighted blend

—

— vs spot

Recommendation

n/a

0 of 0 methods

Method spread

0bull0bear

±5% threshold

Analyst PT consensus: $7.00 (+340.25%)

Price change · trailing returns

Live

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
-1.85%	-8.62%	-2.45%	-4.22%	-16.75%	-23.19%	-24.29%	+9.60%	-56.08%	-56.08%	-56.08%

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Aftermarket

Live

Jun 08, 08:10 PM

Last trade

$1.59

107 sh

Bid

$1.56

19 sh

Ask

$1.61

855 sh

Spread

$0.050

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Communication Services
+0.46%
Financial Services
+0.21%
Energy
-0.00%
Technology
-0.09%
Consumer Cyclical
-0.14%
Consumer Defensive
-0.45%
Healthcare
-0.51%
Industrials
-0.74%
Basic Materials
-1.37%
Utilities
-1.56%
Real Estate
-1.59%

Top industries (issuer's industry highlighted)

Biotechnology
-2.38%
Solar
-8.68%
REIT - Healthcare Facilities
-3.60%
Copper
-3.14%
Financial - Mortgages
-3.03%
Construction Materials
-2.63%
Communication Equipment
-2.56%
Auto - Dealerships
+2.54%
Medical - Healthcare Information Services
-2.46%
Rental & Leasing Services
+2.39%
Medical - Healthcare Plans
+2.36%
Trucking
+2.34%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for OKYO.

Peers

No peer list available for OKYO.

Total assets

—

Total debt

—

Cash & equiv

—

Operating CF

—

Free cash flow

—

Buybacks

—

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin